A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Clinical trial NCT00526617 · COMPLETED

Trial details

NCT number: NCT00526617
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-hematologic Malignancies Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma

Start date: 2007-08-01
Primary completion: 2010-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.